Market Overview

Safeguard Scientifics to Release Fourth Quarter and Year-End 2011 Financial Results on Wednesday, February 29


Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it will release its financial results for the fourth quarter and year ended December 31, 2011 prior to market open on Wednesday, February 29, 2012.

Please call at least 10 minutes prior to the call to register.

Date: Wednesday, February 29, 2012

Time: 9:00am EST


Conference ID#: 50250070

Call-in Number: 800-537-0745
(International) +678-825-8236

Replay Number: 855-859-2056
(International) +404-537-3406
Replay available through March 30, 2012 at 11:59pm EDT

Available approximately 24 hours after the conclusion of the call

Speakers: President and CEO Peter J. Boni; Senior Vice President and CFO Stephen T. Zarrilli

Format: Discussion of fourth quarter and year-end 2011 financial results followed by Q&A.

For more information please contact

About Safeguard Scientifics

Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc. (NYSE: SFE) provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine, Specialty Pharmaceuticals and selected healthcare services, and technology companies in Internet / New Media, Financial Services IT, Healthcare IT and selected business services with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, please visit our website at, our blog at, download our web app at, or you can follow us on Twitter (, LinkedIn (, and YouTube (

Safeguard Scientifics
John E. Shave, 610-975-4952
Vice President, Business Development and Corporate Communications


Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional